INSIGHTS ON LIQUID DOSE MANUFACTURING

• Turnkey Dismantling, Modification, And Relocation Of A Multi-Glove Isolator System

  Strategic equipment relocation and retrofitting can reduce capital costs by fifty percent and save months in lead time. Learn how to modernize legacy systems while maintaining full GMP compliance.

• MPLC System: Efficient Purification for Mid-Sized Therapeutics

  Discover how to enhance purification for mid-sized therapeutics with advanced pressure capabilities. Learn to balance automation and regulatory compliance for more reliable, precise batches.

• Ensuring Consistent Quality In Pharmaceutical Water For Injection (WFI) Systems Application Note

  Maintaining high-quality water for injection is essential for pharmaceutical safety. Discover how strategic design, proactive maintenance, and risk-based monitoring ensure reliable results.

• What Biotech Startups Need To Know About Sterile Fill Finish Services

  Sterile fill–finish is a critical, tightly regulated stage for biotechs, demanding strong contamination control, smart CDMO selection, and awareness of capacity, scalability, and regulatory hurdles.

• Isolated GENiSYS C Fill-Finish System: Available For Quick Delivery

  1/17/2025

  Accelerate your parenteral drug production with a fully integrated, isolator-based fill-finish system. Compact design, rapid delivery, and maximum yield for agile drug development.

• Syntegon Virtual Pharma Expo May 2025: Aseptic Manufacturing And Packaging

  5/21/2025

  The 2022 EU GMP Annex 1 revision marks a pivotal shift in sterile manufacturing, emphasizing contamination control, advanced technologies, and global harmonization—driving industry-wide adaptation and regulatory interpretation challenges.

• Meet Regulation Requirements With RTU Vials And Cartridges

  10/9/2025

  Sterile manufacturing remains vital, with resilient supply chains preventing shortages. Industry and regulators prioritize integrity as demand surges, making it the fastest-growing pharmaceutical segment.

• The Challenges Of Developing Combination Products

  3/13/2026

  Examine the regulatory complexity of combination products and learn how holistic development strategies, early equipment decisions, and representative clinical supply reduce risk and costs.

• Afton Scientific Capabilities Update January 2026: Fill/Finish

  1/27/2026

  Here, Michael Dunn outlines our current available capacity, including RABS operations, alongside the commissioning of a new Annex 1–compliant isolator filling line and expanded QC capabilities to ensure reliable, scalable execution.